Table 1.
Patient | T cell | Expression of CXCR3a (% positive cells) | |||
---|---|---|---|---|---|
# | Disease stage (Dukes’) | Culture | Phenotype | Function | |
03123 | B | MLTC | CD4+ | CTL | 76.2 |
05193 | B | MLTC | CD4+ | CTL | 81.7 |
28712 | B | MLTC | CD4+ | CTL | 87.7 |
274405 | B | Reconstruct | CD8+ | NT | 42.4 |
280150 | C | MLTC | CD4+ | Th | 88.7 |
280291 | A | Reconstruct | CD4+ | Th | 43.7 |
280321 | A | MLTC | CD4+ | NT | 71.7 |
281412 | C | Reconstruct | CD4+ | NT | 85.0 |
281638 | B | Reconstruct | CD4+/CD8+ | NT | 30.4 |
1003485 | A | Reconstruct | CD4+/CD8+ | NT | 47.0 |
NT not tested
aCXCR3 expression was determined by FACS analysis